GL1X · GenesisL1 explorer

Research workbench

Crystal structure of xeg-xyloglucan

Analyse Crystal structure of xeg-xyloglucan in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VL9
Type
protein
Length
443 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Xyloglucan-specific endo-beta-1,4-glucanase a
EC
3.2.1.151
UniProt
O94218
Ligands
BGC, XYS
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 57% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AXyloglucan-specific endo-beta-1,4-glucanase a (EC 3.2.1.151)protein2227% helix, 57% strandO94218
BXyloglucan-specific endo-beta-1,4-glucanase a (EC 3.2.1.151)protein2217% helix, 57% strandO94218

Ligands and binding sites

  • BGC · beta-D-glucopyranose · sugar · 8 copies · chains A, B
  • XYS · alpha-D-xylopyranose · sugar · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16140.640.7562BGC, XYS
21240.400.7528BGC

Interfaces

1 interface between chains.

  • A–B · 271 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3VL9 · Crystal structure of xeg-xyloglucan · the same entry in another collection · chain A against A, TM-score 1.00
  • O94218 · AlphaFold monomer V2.0 prediction for xyloglucan-specific endo- beta-1,4-glucanase a… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.